Of note, this discrepancy was largely due to insufficient neoplastic tissue in the sample, most likely resulting from the fact that BRAF-mutant tumors are generally associated with mucinous adenocarcinoma that contain fewer tumor cells. The gene discussed is BRAF; the disease is neoplasm.